The aberrant immune response found in IBD is prompted by different cytokines – small signaling proteins secreted by various cells, including immune cells – that activate the immune system, causing chronic inflammation.
Now researchers led by Jesús Rivera-Nieves, MD, of the Inflammatory Bowel Disease Center, Division of Gastroenterology at the University of California, San Diego School of Medicine, have discovered that expression of a newly identified human cytokine – Interleukin 37 (IL-37) – protects mice from colitis. The study will be published this week in Proceedings of the National Academy of Sciences (PNAS).
IL-37 is a member of the IL-1 family and functions as an inhibitor of innate inflammation and immunity. While most molecules in the IL-1 family appear to promote an inflammatory response, IL-37 modulates or downgrades inflammation.
Charles A. Dinarello, MD, from the University of Colorado, recently expressed human IL-37 in lab mice, which do not have an orthologue, or similar molecule, for this particular cytokine. Nonetheless, IL-37 works the same in both mice and humans. The mice were then fed water containing dextran sulfate sodium (DSS), a substance that induces colitis, to see whether IL-37 provided protection from intestinal inflammation.
It did. "While we still don't understand its mechanism of action, our hope is that, in the future, scientists may be able to engineer cells to overproduce IL-37 and use it to treat or control an overactive immune system in humans," said Rivera-Nieves.
That would represent a major advance in treating IBD, particularly for the 30 to 50 percent of IBD patients for whom highly effective biological therapies – tumor necrosis factor inhibitors – don't work, or for an even larger percentage of patients whose symptoms eventually return.
Co-authors of the paper are Eoin N. McNamee and Almut Grenz of the Mucosal Inflammation Program, Department of Medicine, Children's Hospital Colorado and the University of Colorado Denver; Joanne C. Masterson, Mucosal Inflammation Program, Department of Medicine, Children's Hospital Colorado and Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Gastrointestinal Eosinophilic Disease Program, Children's Hospital Colorado; Paul Jedlicka and Martine McManus, Department of Pathology, University of Colorado Denver; Colm B. Collins, Mucosal Inflammation Program, Department of Medicine, Children's Hospital Colorado and Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Gastrointestinal Eosinophilic Disease Program, Children's Hospital Colorado; Marcel F. Nold and Claudia Nold-Petry, Division of Infectious Diseases, University of Colorado Denver; Philip Bufler, Children's Hospital, Ludwig-Maximilians University, Munich, Germany and Charles A. Dinarello, Division of Infectious Diseases, University of Colorado Denver.
Funding for this research was provided by the NIH/NIDDK and the Crohn's and Colitis Foundation of America.
The cause or causes of IBD are not known, but are thought to involve genetic, immunologic and environmental factors, such as the intestinal microflora, diet and smoking. IBD is more common in developed countries. A chronic, intermittent disease, the peak age of onset is 15 to 30 years old, but it may occur at any age. Symptoms may include abdominal cramps and pain, diarrhea, loss of appetite and fever. Ulcerative colitis is slightly more common in males. Crohn's disease (another common form of IBD) occurs marginally more often in females.
Debra Kain | EurekAlert!
Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel
Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)
The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.
Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...
A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.
The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
25.05.2018 | Event News
02.05.2018 | Event News
13.04.2018 | Event News
25.05.2018 | Event News
25.05.2018 | Machine Engineering
25.05.2018 | Life Sciences